SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Ridgepost Capital drew $139 million on its revolving credit facility and increased aggregate revolving commitments by $20 million under its Credit Agreement, with the proceeds used to fund the Stellus Capital Management acquisition.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from PepGen's 2026 Annual Meeting held on June 18, 2026. The filing reports voting outcomes for two proposals: election of three Class I directors (Mayer, Resnick, and Wyman) and ratification of KPMG LLP as independent auditor, with detailed vote tallies for each. This is a textbook Item 5.07 disclosure and is material to investors as it reflects stockholder approval of board composition and auditor selection.
View raw filing on EDGAR →Blue Owl Technology Finance Corp. entered into a Fourth Amendment to its Senior Secured Credit Agreement, extending the revolver maturity to June 2030 and scheduled maturity to June 2031, increasing the accordion provision to $4.01 billion, and adjusting sublimits and covenants. This amendment materially alters the Company's direct financial obligations and capital structure.
View raw filing on EDGAR →Public Storage announced entry into a definitive agreement to acquire Public Storage Canada for approximately $1.2 billion USD, consisting of $889 million in OP units, $310 million in cash, and potential earn-out consideration of up to $288 million. The acquisition includes 68 properties representing 5.3 million square feet and marks a strategic entry into the Canadian self-storage market.
View raw filing on EDGAR →Kendall Forbes, Executive Vice President of Sales & Operations since the company's founding in 2004, is retiring effective July 1, 2026, after 22 years of service.
View raw filing on EDGAR →David Morris is appointed Chief Operating Officer (promoted from CFO) and Will Mudd is appointed Chief Financial Officer (promoted from Senior Vice President, Finance), both effective July 1, 2026, as part of the company's executive leadership succession planning.
View raw filing on EDGAR →This 8-K Item 5.07 discloses the final voting results from American Well's 2026 annual stockholder meeting held on June 16, 2026, covering three proposals: election of directors (Dr. Ido Schoenberg), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory vote on named executive officer compensation. The filing presents the vote tallies (For, Withheld, Broker Non-Votes) for each proposal, which is the core disclosure required under Item 5.07 for shareholder vote results.
View raw filing on EDGAR →Seadrill announced an extension of its $500 million share repurchase program through December 31, 2026, with approximately $208 million remaining available as of June 19, 2026.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Equity Residential's June 18, 2026 Annual Meeting of Shareholders under Item 5.07. The filing reports final voting tallies for three proposals: election of ten trustees, ratification of Ernst & Young LLP as independent auditor, and advisory approval of executive compensation. All three proposals passed with substantial majorities, making this a routine but material governance disclosure required by Item 5.07.
View raw filing on EDGAR →CytomX held its Annual Meeting on June 17, 2026, with stockholders voting on seven proposals including election of Class II directors (Matthew P. Young and Elaine V. Jones Ph.D.), ratification of Ernst & Young LLP as auditor, authorization of additional common shares, amendments to the 2015 Equity Incentive Plan and Employee Stock Purchase Plan, advisory approval of named executive officer compensation, and the frequency of future advisory compensation votes.
View raw filing on EDGAR →Stockholders approved amendments to the Company's 2015 Equity Incentive Plan (increasing authorized shares by 6.5 million) and the Employee Stock Purchase Plan (increasing authorized shares by 1 million), expanding the pool of shares available for equity compensation and employee stock purchase eligibility.
View raw filing on EDGAR →This Item 5.07 disclosure reports the final voting results from Atea Pharmaceuticals' June 18, 2026 Annual Meeting of Stockholders, including the election of three Class III directors (Jerome Adams, Howard Berman, and Barbara Duncan), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The filing presents certified vote tallies for each proposal and confirms their passage, which is the core purpose of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →Apollo Debt Solutions BDC sold 2,378,661 unregistered Class I Common Shares for $56.8 million to feeder vehicles, relying on Section 4(a)(2) and Regulation S exemptions from Securities Act registration.
View raw filing on EDGAR →Apollo Debt Solutions BDC declared distributions for each class of common shares on June 22, 2026, with per-share amounts of $0.1800 gross (varying net amounts after fees), payable to shareholders of record as of June 30, 2026, and to be paid on or around July 29, 2026, in cash or through the Fund's distribution reinvestment plan.
View raw filing on EDGAR →Eledon Pharmaceuticals held its Annual Meeting of Stockholders on June 22, 2026, at which shareholders voted on and approved three proposals: election of Class III Directors (Gros, Hillson, Robinson), approval of an amendment to increase authorized common shares from 300 million to 450 million, and ratification of Deloitte & Touche LLP as independent auditor.
View raw filing on EDGAR →This Item 7.01 disclosure is a shareholder letter from Apollo Debt Solutions BDC reporting quarterly performance metrics (net total return of +1.4% for the quarter, 1.5% year-to-date), investor flows ($0.3B gross inflows in Q2, $1.0B year-to-date), redemption activity (16.8% redemption requests, 5% honored), portfolio composition and credit quality metrics, and strategic positioning in the direct lending market. While it contains performance data, the disclosure is primarily operational and strategic in nature—discussing market conditions, capital deployment, portfolio health, and competitive positioning—rather than constituting a formal earnings release or financial results announcement. The material information about net outflows (~$0.4B, 3% of NAV) and redemption trends would affect investor assessment of the fund's capital flows and stability.
View raw filing on EDGAR →nCino held its Annual Meeting of Stockholders on June 18, 2026, with shareholders voting on and approving four proposals: election of directors (Jon Doyle, William Spruill, Diego Dugatkin, and Andy Yasutake), ratification of Ernst & Young LLP as independent auditor, advisory approval of named executive officer compensation, and approval of a charter amendment permitting stockholder removal of directors with or without cause.
View raw filing on EDGAR →The disclosure centers on the separation of Randall L. Baker, Chief Operating Officer, effective June 16, 2026. While the filing mentions severance benefits under the Executive Severance Plan, the principal disclosed action is the departure of a named executive officer from his role, making this an exec_departure event. The COO position is material to a reasonable investor's assessment of the company's leadership and operations.
View raw filing on EDGAR →Fortress Private Lending Fund entered into Amendment No. 3 to its Scotiabank ABL Credit Agreement, increasing the maximum aggregate commitments from $600 million to $950 million—a $350 million expansion of the credit facility with adjusted pricing terms.
View raw filing on EDGAR →On June 22, 2026, JHCPIF entered into an Agreement and Plan of Merger with MPCF and related parties, whereby Merger Sub will merge with MPCF, and the surviving entity will then merge into JHCPIF. This is a material acquisition/merger transaction requiring shareholder approval, with closing anticipated in Q3 2026. The exchange ratio is based on NAV calculations, and the transaction is structured as a tax-free reorganization under Section 368(a) of the Internal Revenue Code.
View raw filing on EDGAR →On June 22, 2026, Manulife Private Credit Fund entered into an Agreement and Plan of Merger with John Hancock Comvest Private Income Fund, providing for a two-step merger in which MPCF will merge into JHCPIF. This is a material acquisition/change of control transaction requiring shareholder approval and SEC registration, with closing anticipated in Q3 2026. The merger consideration is based on an exchange ratio tied to the net asset values of both funds as of the determination date.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from the Annual Meeting of Stockholders held on June 22, 2026. The filing presents tabulated voting results for two proposals: (1) election of eight directors and (2) ratification of BDO USA, P.C. as independent auditor. Item 5.07 is the designated 8-K item for shareholder vote results, and the prose explicitly states vote counts for each director and proposal, making this a material governance event affecting investor understanding of board composition and auditor selection.
View raw filing on EDGAR →This Item 5.07 discloses the final results of a Special Meeting of Stockholders held on June 18, 2026, where stockholders voted on two proposals to approve issuances of common stock pursuant to Nasdaq Rule 5635 — specifically approving up to 925,927 shares from Series A and B Warrants (Proposal 1) and 2,344,828 shares from Common Warrants (Proposal 2). Both proposals passed with overwhelming majorities. The disclosure of shareholder vote results at a stockholder meeting is the core purpose of Item 5.07, and approval of dilutive warrant exercises is material to investors assessing capital structure and ownership dilution.
View raw filing on EDGAR →This Item 5.07 disclosure reports the final results of Unicycive's Annual Meeting of Stockholders held on June 19, 2025, including the election of three directors (Dr. Shalabh Gupta, Dr. Sandeep Laumas, and D. Sarawati Kenkare-Mitra) and ratification of Grassi & Co. CPAs as the independent auditor. The filing explicitly presents vote tallies for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →GCL's publishing subsidiary 4Divinity has secured exclusive worldwide publishing and distribution rights for the action-RPG "A Whisper of Fall: Jinyiwei" from Chengdu Cangmo. This represents a material strategic business partnership and content acquisition that expands 4Divinity's portfolio with a premium IP title planned for global launch in 2027. While not a traditional M&A transaction, the exclusive publishing agreement is a significant operational and commercial milestone for the company's gaming business.
View raw filing on EDGAR →The filing discloses that Karine Pinto-Flomenboim, the Company's Chief Financial Officer, has accepted a position at another company (Valens Semiconductor) and will depart her role on August 8, 2026, following Q2'26 results release. This is a departure of a named executive officer and material to investors assessing the registrant's financial leadership and continuity.
View raw filing on EDGAR →The press release announces the appointment of Karine Pinto-Flomenboim as Chief Financial Officer of Valens Semiconductor, effective August 9, 2026, succeeding Guy Nathanzon who is stepping down. This is a material executive appointment at the C-suite level (CFO), which would affect a reasonable investor's assessment of the company's leadership and financial stewardship. The disclosure includes her extensive background in semiconductor finance and publicly listed companies, making this a clear exec_appointment event.
View raw filing on EDGAR →The Item 8.01 disclosure centers on the appointment of Dr. Craig Ciesla as Chief Technology Officer (CTO) of IQM Quantum Computers and the transition of Dr. Inés de Vega to Chief Scientist, announced via press release on June 19, 2026. While the filing also references the ongoing business combination with RAAQ, the substantive event disclosed is the executive appointment of Ciesla to a senior leadership role and the role transition of de Vega. This is material as it reflects significant leadership changes at a company preparing for a Nasdaq listing.
View raw filing on EDGAR →MoonLake disclosed Week 52 Phase 3 VELA trial results for sonelokimab in hidradenitis suppurativa, showing 67.2% HiSCR75 response and 26.0% inflammatory remission, along with interim Week 24 adolescent data (~68% HiSCR75 response). The company announced plans to submit a Biologics License Application (BLA) to the FDA by end of September 2026, representing a material clinical development milestone with significant regulatory and commercial implications.
View raw filing on EDGAR →The press release announces the results of an extraordinary general meeting of shareholders held on June 19, 2026, where shareholders voted to approve a merger agreement between LakeShore Biopharma, Oceanpine Skyline Inc., and Oceanpine Merger Sub Inc. Approximately 92.3% of outstanding shares voted, with 86.2% of votes cast approving the merger. This is a shareholder vote result on a material transaction (merger) that will result in the company becoming privately held and delisted from public markets.
View raw filing on EDGAR →On June 16, 2026, Olenox Industries Inc. completed the acquisition of 100% of the issued and outstanding membership interests of CS Digital Ventures, LLC, a digital infrastructure company with 35 megawatts of installed power capacity in energy-intensive data centers and bitcoin mining operations. The transaction involved $30 million in upfront consideration ($14 million in Series E Preferred Stock and $16 million in a promissory note), warrants for 1.5 million common shares, and up to $20 million in earnout shares tied to revenue and EBITDA milestones.
View raw filing on EDGAR →In connection with the CS Digital acquisition, Olenox issued a promissory note (Seller Note) valued at $16 million as part of the upfront acquisition consideration, creating a new direct financial obligation.
View raw filing on EDGAR →Olenox issued $14 million in Series E Preferred Stock and warrants for 1.5 million common shares to the sellers of CS Digital as partial acquisition consideration, relying on Section 4(a)(2) and Rule 506(b) exemptions from registration.
View raw filing on EDGAR →NutriBand entered into an amended $5,000,000 credit line facility on June 1, 2026, replacing an expiring facility from March 2023. This constitutes creation of a new direct financial obligation—a credit facility amendment—which is a material debt issuance event. The facility provides critical financing for the company's lead product through FDA approval and commercial manufacturing, making it material to investors assessing the registrant's capital structure and operational runway.
View raw filing on EDGAR →This press release announces the successful completion of Part A treatment for all 24 participants in Clearmind's Phase I/II clinical trial of CMND-100 for Alcohol Use Disorder. The company states it is "currently assessing the dataset and, assuming results remain favorable, intends to initiate the next stage of the clinical program." This is a material clinical development milestone for a clinical-stage biotech company, but it is not a discrete earnings release (no financial results disclosed), nor does it fit other specific event categories. It represents a significant operational/clinical progress event that would affect a reasonable investor's assessment of the company's pipeline advancement.
View raw filing on EDGAR →Nexera issued a $2,000,000 convertible promissory note (purchased for $1,800,000 cash) on June 18, 2026, together with a warrant to purchase 3,212,336 ordinary shares at $0.734 per share. The note is convertible at the holder's option at a variable price floor of $0.14680 per share, creating substantial dilution potential. This is a classic dilutive private placement of convertible debt and warrants, materially affecting shareholder equity and voting power.
View raw filing on EDGAR →BitFuFu announced board approval of a US$5 million share repurchase program effective June 24, 2026, for a 24-month period. Share repurchases are a form of capital return to shareholders and fall within the dividend_distribution category, which encompasses "share-repurchase programs." The announcement explicitly states the program "aims to demonstrate the Company's confidence in its long-term business prospect and to deliver value to shareholders," indicating a material capital allocation decision.
View raw filing on EDGAR →This press release discloses a treasury portfolio update showing Enlivex holds approximately $1.14 billion in RAIN tokens as of June 20, 2026, with a Treasury NAV per Share of $4.67. While the disclosure updates the market on a material asset holding and its valuation, it does not fit the discrete event categories (no M&A, no earnings release, no executive change, no debt issuance). The treasury composition and mark-to-market valuation are financial in nature but represent an ongoing portfolio status update rather than a specific triggering event, making `financial_other` the most appropriate classification. The materiality is high given the substantial asset value disclosed relative to the company's market position.
View raw filing on EDGAR →The filing discloses that TOP Financial Group has regained compliance with Nasdaq's minimum bid price requirement (Listing Rule 5550(a)(2)) after previously falling below the $1.00 per share threshold for 30 consecutive business days. While the company has now cured the deficiency, the disclosure of the prior non-compliance and the cure is a material delisting-risk event that would affect a reasonable investor's assessment of the company's continued listing status.
View raw filing on EDGAR →Ondas Inc. issued unregistered equity securities to non-U.S. investors under Regulation S, increasing share count and diluting existing shareholders.
View raw filing on EDGAR →Ondas Inc. registered 3,126,979 shares for resale by stockholders who acquired them as consideration in acquisitions of Omnisys Ltd. and World View Enterprises Inc., increasing share count and dilution to existing shareholders.
View raw filing on EDGAR →Lion Group Holding Ltd. entered into an Investment Participation and Economic Interest Arrangement Agreement on June 22, 2026, to participate in Meili Capital Management Limited's acquisition of a 10% equity interest in PT NUSANTARA BUMI SANGKARA for US$12,000,000. This constitutes a material investment/acquisition activity requiring disclosure under Item 1.01 or analogous 6-K provisions. The transaction is subject to customary closing conditions but represents a significant capital commitment and strategic investment decision material to investors.
View raw filing on EDGAR →Ms. Inna Martin resigned from her positions as Director, Chief Operating Officer, and President of Revium Rx, effective immediately on June 16, 2026. The filing centers on her departure from multiple senior leadership roles, with the separation agreement detailing the terms of her exit, including extended stock option exercise periods and sale restrictions. This is a material executive departure affecting the company's leadership structure.
View raw filing on EDGAR →The press release announces NewGen's issuance of 3,666,667 new shares in connection with a "strategic share purchase agreement to acquire a 10% equity interest in K25.ai," coupled with a subsequent US$10 million investment in K25.ai. This constitutes a material acquisition or investment transaction. While the company characterizes it as a strategic investment rather than a full acquisition, the definitive agreement to acquire equity interest in another entity, combined with the substantial capital commitment and the company's stated strategic pivot around this transaction, qualifies as ma_activity under Items 1.01 or 2.01 of the 8-K taxonomy.
View raw filing on EDGAR →Boxlight announced a 1-for-6 reverse stock split of Class A common stock, effective June 22, 2026, explicitly intended to increase the closing bid price above $1.00 per share to maintain compliance with Nasdaq Capital Market Listing Rule 5550(a)(2) (minimum bid price requirement). The reverse split was approved by the Board of Directors and represents a material governance action undertaken to mitigate delisting risk.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results under Item 5.07. The filing reports the outcome of a special meeting held on June 18, 2026, where stockholders voted on a reverse stock split proposal with specific voting tallies: 42,878,771 votes for, 2,210,259 against, and 22,102 abstentions. The reverse stock split authorization is material to investors as it affects share structure and potential delisting risk mitigation.
View raw filing on EDGAR →Greenland Mines entered into a Share Exchange Agreement on June 15, 2026, to acquire approximately 9.9% of AnorTech Inc.'s outstanding common shares (19,958,503 shares) in exchange for 12,400,000 of its own shares, with an additional option to acquire up to 25,168,669 shares.
View raw filing on EDGAR →Lion Group Holding Ltd is soliciting shareholder votes on material proposals at its 2026 Annual General Meeting scheduled for July 13, 2026, including director re-election, adoption of a 2026 Employee Share Incentive Plan, a major share capital reduction (reducing par value from US$0.0001 to US$0.0000001 per share), amendment to the memorandum, and an increase in voting rights for Class B shares (from 10,000 to 100,000 votes per share). The share capital reorganization and voting rights increase represent material changes to the company's capital structure that would affect investor assessment.
View raw filing on EDGAR →Pluri entered into an Advance Subscription Agreement on June 14, 2026, whereby Chutzpah Holdings LP (beneficially owned by board chairman Alexandre Weinstein) advanced $1.25 million to be credited toward the purchase of securities in a future financing to be consummated by August 14, 2026. This arrangement constitutes a dilutive equity issuance commitment.
View raw filing on EDGAR →The Board elected Mr. Doron Shorrer as a director on June 19, 2026, filling a vacancy created by the non-re-election of Mr. Eitan Ajchenbaum at the 2026 Annual Meeting. Mr. Shorrer was appointed as Audit Committee Chairman and sole member of the Investment Committee.
View raw filing on EDGAR →